Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Agile rapeutics

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: Agile Therapeutics Q1 Earnings

Agile Therapeutics (NASDAQ:AGRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

Agile Therapeutics's Return On Capital Employed Insights

Agile Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Agile Therapeutics (NASDAQ:AGRX) reported Q4 sales of $1.51 million. Earnings fell to a loss of $23.36 million, resulting in a 39.26% decrease from last quarter.

Preview: Agile Therapeutics's Earnings

Preview: Agile Therapeutics's Earnings

Agile Therapeutics (NASDAQ:AGRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Agile Therapeutics will report an earnings per share (EPS) of $-0.15.

Organisations

Paramount Global

B of A Securities

American Eagle Outfitters

Endo International

Myovant Sciences

WAVE Life Sciences

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play